Marcaine is one of 61 small molecule programs targeting Total Knee Arthroplasty. It is currently in Phase 1.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
67 competitors in Total Knee Arthroplasty
Naropin
Cyklokapron
Marcaine
Decadron
Medrol
Carbocaine
Journavx
Lexapro
MS Contin
Adrenaline
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details